Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M701797200 on July 9, 2007

J. Biol. Chem., Vol. 282, Issue 40, 29336-29347, October 5, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/40/29336    most recent
M701797200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reddi, A. L.
Right arrow Articles by Band, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reddi, A. L.
Right arrow Articles by Band, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Binding of Cbl to a Phospholipase C{gamma}1-docking Site on Platelet-derived Growth Factor Receptor beta Provides a Dual Mechanism of Negative Regulation*Formula

Alagarsamy Lakku Reddi{ddagger}, GuoGuang Ying{ddagger}, Lei Duan{ddagger}, Gengsheng Chen{ddagger}, Manjari Dimri{ddagger}, Patrice Douillard§, Brian J. Druker, Mayumi Naramura{ddagger}, Vimla Band||**, and Hamid Band{ddagger}**1

From the Divisions of {ddagger}Molecular Oncology and ||Cancer Biology, Evanston Northwestern Healthcare Research Institute, and Department of Medicine, Feinberg School of Medicine and **Department of Biochemistry, Molecular Biology and Cell Biology, Weinberg College of Arts and Science, Northwestern University, Evanston, Illinois 60201, the §Eucodis GmbH, Brunner Strasse 59, 1230 Vienna, Austria, and the Oregon Health and Science University Cancer Institute, Portland, Oregon 97239

Ubiquitin conjugation to receptor tyrosine kinases is a critical biochemical step in attenuating their signaling through lysosomal degradation. Our previous studies have established Cbl as an E3 ubiquitin ligase for ubiquitinylation and degradation of platelet-derived growth factor receptor (PDGFR) {alpha} and PDGFRbeta. However, the role of endogenous Cbl in PDGFR regulation and the molecular mechanisms of this regulation remain unclear. Here, we demonstrate that endogenous Cbl is essential for ligand-induced ubiquitinylation and degradation of PDGFRbeta; this involves the Cbl TKB domain binding to PDGFRbeta phosphotyrosine 1021, a known phospholipase C (PLC) {gamma}1 SH2 domain-binding site. Lack of Cbl or ablation of the Cbl-binding site on PDGFRbeta impedes receptor sorting to the lysosome. Cbl-deficient cells also show more PDGF-induced PLC{gamma}1 association with PDGFRbeta and enhanced PLC-mediated cell migration. Thus, Cbl-dependent negative regulation of PDGFRbeta involves a dual mechanism that concurrently promotes ubiquitin-dependent lysosomal sorting of the receptor and competitively reduces the recruitment of a positive mediator of receptor signaling.


Received for publication, March 1, 2007 , and in revised form, July 2, 2007.

* This work was supported by National Institutes of Health Grants CA 99900, CA99163, CA 87986, and CA76118 (to H. B.) and CA94143, CA96844, and CA81076 (to V. B.); Department of Defense Breast Cancer Research Grants DAMD17-02-1-0303 (to H. B.) and DAMD17-02-1-0508 (to V. B.); Center for Cancer Nanotechnology Excellence Grant NCI 1U54 CA119341-01 (to H. B. and V. B.); the Jean Ruggles-Romoser Chair of Cancer Research (to H. B.); and the Duckworth Family Chair of Breast Cancer Research (to V. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables S1-S3 and supplemental Figs. S1-S6.

1 To whom correspondence should be addressed: ENH Research Institute, 1001 University Place, Evanston, IL 60201. Tel.: 224-364-7401/7424; Fax: 224-364-7402; E-mail: h-band{at}northwestern.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Y. Cha, S. Maddileti, N. Mitin, T. K. Harden, and C. J. Der
Aberrant Receptor Internalization and Enhanced FRS2-dependent Signaling Contribute to the Transforming Activity of the Fibroblast Growth Factor Receptor 2 IIIb C3 Isoform
J. Biol. Chem., March 6, 2009; 284(10): 6227 - 6240.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement